Feature Article: February 2021 – The Epigenetic Revolution, a 3-Part Webinar Series

Register for 3-Part Webinar Series on The Epigenetic Revolution: The Clinical Utility and Application for Epigenetic Testing in Age Management, 3.0 hrs. CME

Jeff Morris

Aging is the number one risk factor for almost all chronic diseases and has always been difficult to objectively assess. The wide phenotypic variation has always kept chronological age from being a reliable clinical biomarker. Now, AMMG presents a three-part webinar series that will share new ways to effectively assess a patient’s aging rates and vet the effect of many age management medicine treatments.

Such assessments are possible because of the advent of new multi-omic diagnostics such as epigenetics, transcriptomics, and proteomics. In particular, many advances have been made to epigenetic testing and the algorithms that can interpret these DNA markers to health related risks and outcomes. Now we can use these epigenetic algorithms to assess immune system function, telomere length, senescence, instantaneous aging rate, and of course how all of these metrics relate to the risk of developing chronic disease. Unlike DNA, changes can be made to reverse the signs of epigenetic aging as a way to improve health. As a result, we can finally treat and test aging with a single test.

This lecture series will talk about the history of this new field, how many are using it, and the best ways to reverse epigenetic aging. If you sign up for this series, you will be able to describe the essential scientific evidence-based information for methods of using epigenetic markers to determine biological age, and ways to predict disease and improve patient health and outcomes; describe and discuss how epigenetic methylation can provide insights into aspects of aging such as rates of aging and telomere length; and discuss new scientific evidence-based interventions such as epigenetic rate of aging derived from genetic testing to facilitate and provide superior patient care and impact patient outcomes.

The webinar presenters are top people in their fields. Luis Martínez, M.D. is a Regenerative Medicine, Anti-aging and Cell Therapy specialist, clinical researcher and biomedical consultant. Heather Smith-Fernandez, M.D. is a Board-certified anesthesiologist and a fellowship-trained interventional pain and regenerative medicine physician. Larry Siegel is an Advanced Practice Registered Nurse and has been practicing medicine for 19 years.

In Lecture #1, Introduction to Epigenetic Methylation: Why it is the Best Age Related Biomarker, Dr. Martinez will discuss the new ways to read epigenetics for age related biomarkers. He explains that every cell in the body has the same DNA; however, it is the cells’ epigenetic programming that gives them their individual phenotypes. Through new developments in computer learning, we now have a way to read these epigenetic markers to predict disease and improve health. Perhaps no area of medicine has benefited more from these developments, because there are amazingly accurate biological age measurements which can be used as an objective measure of the aging process and can successfully quantify the effect of age management interventions.

Lecture #2, Beyond Aging: Epigenetic Diagnostics and the Future of Epigenetic Testing, will show that while epigenetic age is a breakthrough therapy for preventative health, the benefits of methylation data go way beyond aging  In this lecture Dr. Smith-Fernandez will discuss how epigenetic methylation can give us insights into other aspects of aging such as the instantaneous rate of aging, telomere length through epigenetics, senescence, and stem cell depletion. She will also discuss where the field is going in the next 10 years  and how it will change functional medicine.

In the third lecture, Objectively Reverse Epigenetic Biological Age: Evidence Based Interventions and Protocols, Larry Siegel will explain how, as epigenetics research continues to expand to more accurately predict health, we are also learning about how to structure medical interventions to facilitate the best health changes for patients. He will discuss validated interventions to change epigenetic aging, epigenetic rate of aging, and other methylation loci.

Dr. Martinez earned his medical degree at The Ponce School of Medicine and completed his residency training at the prestigious University of Pennsylvania. He also completed an Advanced Training Course in Stem Cells in Cancer at the Ponce Health Sciences University/Magee Research Institute consortium. He is board certified in Clinical Lipidology. Dr. Martinez holds a Master of Public Health with a concentration in Epidemiology and is fellowship trained in Biosecurity. He is the president of Xanogene Clinic, which specializes in Regenerative and Age Management Medicine. He also founded and presides over Regenera Global, a multinational corporation specializing in biotech product development, research, and clinical consulting. Dr. Martinez is also Co-Founder of the Clinical Peptide Society, a U.S.-based professional organization aimed at educating physicians and advancing the use of peptide therapeutics. Along with the Age Management Medicine Group, he and his colleague have developed the world’s first Peptide Certification Program and have so far trained and educated over 400 physicians. He additionally trains physicians in other aspects of Regenerative and Age Management Medicine through his physician training portal, Elite Group MD. Dr. Martinez recently founded, alongside various colleagues, the Senolytic Therapy Network. It is the first professional organization dedicated to advancing the science and clinical applications of senolytic therapies.

Dr. Smith-Fernandez is Founder & Medical Director, Regenerative Institute of Medicine, Naples, Florida. She is the founder of Peptology® a trademarked set of protocols for the clinical application of peptides in specific areas of clinical practice. Dr. Smith-Fernandez graduated in the first ever class of physicians trained and certified in peptide medicine by A4M, and has been conducting clinical research in the field of peptides, especially combined with regenerative procedures, for her patients since 2015. She utilizes peptides in all areas of her practice and is one of the leading clinical peptide experts in the world, lecturing throughout the United States, and training other physicians through her online or in-person workshops. She has been in the forefront of peptide medicine and in 2019, she started training other physicians through her online and in-person workshops.  In addition, she is also a certified CMA provider and certified in BHRT, including with BioTE Medical. She helped develop and teach the BioTE peptide training which launched in 2020.  

Larry Siegel, APRN, MSNN, founded Yunique Medical Services in 2016 and now offers his services at several clinics in Central Florida, including Fruitland Park (The Villages), Ocala, Daytona, and Orlando. He is utterly dedicated to his profession and seeks continuous improvement, with a diversity of specialist skills, certifications, and knowledge that make him the best in his field. As a SottoPelle certified physician, he specializes in hormone therapy and delivers a choice of sustainable treatments that address the underlying cause of his patients’ symptoms. Larry is a Peptide Mastermind and Clinical Fellow as well as an Elite Cellular and Performance Mastermind Fellow. He practices functional medicine, provides precision therapies, is an epigenetic expert, and is devoted to giving the highest quality patient-centered care. He is also a committed clinical researcher. His passion and goals are all about producing a life-changing experience for his patients and improving their quality of life.

To sum up, in this 3-part CME series you’ll learn about the history of this new field, how many are using it, and the best ways to reverse epigenetic aging. You’ll also learn how to treat and test aging with a single test, how to use epigenetic algorithms to assess immune system function, telomere length, senescence, instantaneous aging rate, and of course how all of these metrics relate to the risk of developing chronic disease.

The webinars are scheduled for February 24, March 3 and March 10. For further details, visit www.agemed.com.

Register for the webinar series here.

After registering on the AMMG website you’ll receive access to the Epigenetic Revolution Webinar Series page containing information about joining the live meetings and obtaining your CME credits.

Note: Funding for this webinar/online education course is provided through a grant from TruDiagnostic & Tailor Made Compounding.

 

 

1